Pfizer Inc.; market cap as of 27/11/2015: $202.7bn Allergan plc; market cap as of 27/11/2015: $126bn Introduction On November 23, 2015, Pfizer Inc. (NYSE: PFE) and Allergan plc (NYSE: AGN) announced that their boards of directors have unanimously approved a definitive merger agreement under which Pfizer will combine with Read more…
Actavis plc.; market cap (as of 21/11/2014): $70.5bn Allergan Inc.; market cap (as of 21/11/2014): $63.3bn Introduction The growing emphasis we put on health and quality of life, and the scientific advancements which are making this possible, are putting the pharmaceutical and medical industries in the spotlight. The recent surge Read more…
Valeant Pharmaceuticals International; Market Cap. (as of 3/10/2014): $42.9bn Allergan Inc.; Market Cap. (as of 3/10/2014): $53.64bn As low debt obligations alongside large cash holdings and patent expiration liabilities continue to foster a conducive environment for M&A activity in the pharmaceutical and biotech industry another multi-billion dollar struggle has emerged: Read more…
Pfizer Inc, Market Cap (as of 23/05/2014): $188.37bn AstraZeneca PLC, Market Cap (as of 23/05/2014): $91.78bn In its bid for AstraZeneca, Pfizer, the famous Viagra producer, failed to make a satisfactory offer and turned the potential biggest foreign takeover in UK corporate history into failure. It all happened on May Read more…